Results 301 to 310 of about 1,229,162 (345)

Plant Viral Vectors for Vaccine Development. [PDF]

open access: yesVaccines (Basel)
Shahgolzari M   +4 more
europepmc   +1 more source

Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model

open access: yesAdvanced Science, EarlyView.
We present a novel DNA vaccine platform featuring intrinsic, non‐targeting dsRNA that significantly enhances immune responses by activating the regulated IRE1‐dependent decay‐RIG‐I signaling pathway. This research elucidates a previously uncharacterized mechanism for dsRNA‐mediated innate immune activation.
Min‐Syuan Huang   +10 more
wiley   +1 more source

Vaccines and vaccination

open access: yes, 2010
John D. Grabenstein   +2 more
openaire   +1 more source

Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to Vaccination

open access: yesAdvanced Science, EarlyView.
Scaffolding IL‐21 on the surface of a self‐assembling nanoparticle immunogen drives improved germinal center and humoral immune responses. These nanoparticle immunoadjuvant complexes (NICs) functionally modulate the germinal center driving improved somatic hypermutation and antibody maturation, suggesting this platform has potential utility as a ...
Nicholas J. Tursi   +21 more
wiley   +1 more source

Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024-2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method. [PDF]

open access: yesVaccines (Basel)
Choi YJ   +15 more
europepmc   +1 more source

Family Decision to Immunize Against Respiratory Syncytial Virus and Associations with Seasonal Influenza and COVID-19 Vaccination. [PDF]

open access: yesVaccines (Basel)
Kaye LD   +7 more
europepmc   +1 more source

An Overview of the Factors Related to <i>Leishmania</i> Vaccine Development. [PDF]

open access: yesVaccines (Basel)
Passero LFD   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy